- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Inefficient Market Opportunities
Global Pharmaceuticals & Biotech Inefficient Market Opportunities
UPDATED Jul 03, 2022
Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XOMAXOMA | US$20.84 | 0.2% | -37.4% | US$238.0m | US$62.50 | PE19.8x | E58.1% | n/a | ||
| PHAREgyptian International Pharmaceutical Industries | ج.م29.66 | -1.0% | -34.7% | ج.م2.9b | ج.م67.98 | PE5.4x | E16.2% | 5.1% | ||
| B8FEBiofrontera | €2.12 | 24.7% | -60.0% | €65.2m | €6.18 | PE4.3x | E30.9% | n/a | ||
| B8FEBiofrontera | €2.22 | 37.9% | -51.7% | €65.2m | €6.47 | PE4.3x | E30.9% | n/a | ||
| BFAG.YBiofrontera | €2.27 | 2.3% | -63.3% | €65.2m | €6.61 | PE4.3x | E30.9% | n/a | ||
| AYUR.FAyurcann Holdings | CA$0.081 | -15.6% | n/a | CA$12.1m | n/a | PE30.3x | E138.3% | n/a | ||
| AYURAyurcann Holdings | CA$0.10 | -9.1% | -52.4% | CA$12.1m | n/a | PE30.3x | E138.3% | n/a | ||
| 3ZQ0Ayurcann Holdings | CA$0.067 | -16.8% | -48.2% | CA$12.1m | n/a | PE30.3x | E138.3% | n/a |
Page 1 of 1